Implications of Expanded Advanced Fibrosis Screening Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease in Primary Care

Key Points

• Screening strategies may improve the early detection of advanced fibrosis in patients with steatotic liver disease, enhancing treatment options.
• Advanced fibrosis was identified in a significant number of patients with metabolic dysfunction-associated steatotic liver disease, highlighting the need for proactive screening.
• Observational analysis across multiple primary care settings assessed the implications of various screening strategies on patient outcomes.
• These findings underscore the importance of implementing advanced screening techniques in primary care to manage liver disease effectively.